Literature DB >> 21993571

Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.

Jung-Joo Hwang1, Sang-Hyun Min, Ki-Hyuk Sin, Young-Shin Heo, Kil-Dong Kim, Ook-Joon Yoo, Seung-Hyo Lee.   

Abstract

Protein tyrosine phophatases (PTPs) are implicated in the tumorigenesis and metastasis of human cancer. The phosphatase of regenerating liver (PRL) gene family, a subgroup of PTPs is also linked to these processes. In many solid cancers, high levels of PRL-3 expression are related with metastasis and poor prognosis. However, the expression patterns of PRL-1 and -2 have not been explored in lung cancer yet. Thus, we investigated the expression levels of PRL-1, -2 and -3 in the tissues of primary lung cancer patients. The protein expression levels of PRL-2, but not PRL-1 and -3 were increased in cancer tissues. However, there was no correlation between mRNA and protein expression levels of the PRLs. Reporter assays showed that PRLs suppressed the activity of the p21 promoter but promoted AP-1 activity. Furthermore, transfection of PRLs showed significantly increased cell proliferation. Therefore, these results suggest that PRL-2 plays an important role in lung cancer and can be a biomarker of lung cancer, substituting for the function of other PRLs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993571     DOI: 10.3892/or.2011.1495

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Overexpression of PTP4A1 is associated with poor overall survival in non-small cell lung cancer.

Authors:  Tao Wang; Xiaoyi Shi; Zhichao Wang; Xinyang Liu; Guoliang Zhang; Qikun Zhu; Lili Mi; Rui Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.

Authors:  Sheng-Yi Lin; Yue-Xun Lee; Sung-Liang Yu; Gee-Chen Chang; Jeremy J W Chen
Journal:  Oncotarget       Date:  2016-04-19

3.  Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.

Authors:  Jung Eun Park; Hiu Fung Yuen; Jian Biao Zhou; Abdul Qader O Al-Aidaroos; Ke Guo; Peter J Valk; Shu Dong Zhang; Wee Joo Chng; Cheng William Hong; Ken Mills; Qi Zeng
Journal:  EMBO Mol Med       Date:  2013-08-08       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.